- Used, but in brand new condition!
- 12 Lead Interpretive ECG Machine
- Prints on full size paper
- 60 day warranty!
The PageWriter 300pi delivers a wealth of advanced features designed to save you time and simplify the acquisition, interpretation, storage and transmission of ECGs. This standard cardiograph captures accurate, simultaneous 12-lead ECGs on full-size paper with no cutting or pasting. And it features an alphanumeric keyboard, so you can enter patient IDs in seconds.
When you move up from the PageWriter 200 to the 300pi, you get the same highly accurate adult and pediatric interpretive algorithm used in our PageWriter XLi cardiograph. And its built-in ECG Analysis Program produces reports that include ECG measurements and analysis statements. What's more, the PageWriter 300pi also offers advanced predictive instrument programs especially helpful to physicians making critical decisions in Emergency Departments.
ACI-TIPI (Acute Cardiac Ischemia - Time Insensitive Predictive Instrument) helps you predict the probability of acute cardiac ischemia, while TPI (Thrombolytic Predictive Instrument) helps you identify patients having acute myocardial infarction who might benefit from thrombolytic therapy. The PageWriter 300pi is a light-weight cardiograph for use in offices, clinics, and hospitals. It offers an unbeatable combination of quality and value.
Your PageWriter 300pi cardiograph:
- Acquires 12 leads simultaneously.
- Allows you to check lead quality on the preview screen before printing the ECG.
- Provides selectable formats (Auto and Manual).
- Reports measurements of the ECG.
- Operates on a rechargeable battery. AC power charges the battery.
- Has a digital array printer with continuous-feed paper.
- Has a 200 sheet Z-fold paper capacity.
In addition to the features listed above, the PageWriter 300pi cardiograph can analyze and interpret the ECG. The PageWriter 300pi also includes Predictive Instrument applications that detect Acute Myocardial Infarction and Acute Cardiac Ischemia, as well as calculate predicted outcome with and without thrombolytic therapy.